Epidemiologic Evaluation of Cardiovascular Risk in Patients Receiving Milnacipran, Venlafaxine, or Amitriptyline: Evidence from French Health Data. [electronic resource]
Producer: 20151214Description: 179-88 p. digitalISSN:- 1542-6270
- Adrenergic Uptake Inhibitors -- adverse effects
- Adult
- Amitriptyline -- adverse effects
- Antidepressive Agents -- adverse effects
- Cardiovascular Diseases -- chemically induced
- Cyclopropanes -- adverse effects
- Female
- Heart Failure -- chemically induced
- Humans
- Male
- Middle Aged
- Milnacipran
- Myocardial Infarction -- chemically induced
- Retrospective Studies
- Risk
- Selective Serotonin Reuptake Inhibitors -- adverse effects
- Stroke -- chemically induced
- United States
- Venlafaxine Hydrochloride -- therapeutic use
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.